Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients
| Autor: | Babaoglu, H., Tufan, A., Haznedaroglu, S., Ozturk, M. A., Goker, B., Salman, R. B., Guler, A. A., Karadeniz, H., Satis, H., Ozturk, B. O., Sodan, H. N., Eroglu, G. A., Atas, N. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Popis: | Objective. Anakinra and canakinumab are the most commonly used agents in colchicine resistant/intolerant patients. In this study we investigated long-term efficacy and safety of anakinra and canakinumab. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|